Jonathan G. Kaye, MD
Vice Chair, Department of Biomedical Sciences
Director, Division of Immunology Research
Scientific Director, Research Core Facilities
Professor, Biomedical Sciences
Professor, Medicine
Clinical Office
Jonathan G. Kaye, PhD
Vice Chair, Department of Biomedical Sciences
Director, Division of Immunology Research
Scientific Director, Research Core Facilities
Professor, Biomedical Sciences
Professor, Medicine
Research Profile
The laboratory of Jonathan Kaye, PhD, works on the molecular regulation of cell fate decisions in the immune system, with particular focus on T lymphocytes and innate lymphoid cells.
Education
- Undergraduate: California Institute of Technology, 1976
- Doctorate: Yale University, 1985
- Post Doctorate: University of California, San Diego, 1990
Cedars-Sinai Affiliations
- Cancer
- Biomedical Sciences
- Medicine
Awards & Activities
- Invited Speaker, Cytokines in T Cell and ILC Differentiation Symposium, NIH, Bethesda, MD, 2018
- Chair, NIH, Special Emphasis Panel, NIAID Investigator Initiated Program Project Applications, 2018
- Chair, NIH, Member Conflict Panel, Immune Mechanisms, 2017
- Chair, NIH Investigations on Primary Immunodeficiency Diseases Special Emphasis Panel, 2010-17
- Section Editor: Journal of Immunology, 2009-2013
Publications
Click here for a list of peer-reviewed publications.
- Page N, Klimek B, De Roo M, Steinbach K, Soldati H, Lemeille S, Wagner I, Kreutzfeldt M, Di Liberto G, Vincenti I, Lingner T, Salinas G, Brück W, Simons M, Murr R, Kaye J, et al. Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8+ T Cells. Immunity. 2018 May 15;48(5):937-950.e8. PMCID: PMC6040915
- Harly C, Cam M, Kaye J, Bhandoola A. J Exp Med. 2018 Jan 2;215(1):249-262. PMCID: PMC5748853
- Seehus CR, Kadavallore A, Torre B, Yeckes AR, Wang Y, Tang J, Kaye J. Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nat Commun. 2017 Dec 1;8(1):1900. PMCID: PMC5711851
Languages Spoken
English